PECAM1 and neoplasm: To explore how anti-CD47 Ab impacts tumor vascular wall cell coverage, IF double staining of α-SMA and CD31 was used, and it was found that the percentage of α-SMA-positive wall cells covering the blood vessels was increased in the anti-CD47 Ab-treated group compared to the control group (Figure 4B).